BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2002
View Archived Issues
Oncopharm patents antitumor cephalotaxines
Read More
Esteve presents novel anesthetics, sedatives, etc.
Read More
Novel HIV RT inhibitors identified at Parker Hughes Institute
Read More
beta3-Adrenoceptor agonists and their use in obesity, diabetes, etc.
Read More
New GSK-3 inhibitors in early development at Novo Nordisk
Read More
Multidrug resistance modulators identified at Procter & Gamble
Read More
Novel erythromycin A analogues in the pipeline at Ortho-McNeil
Read More
XTL-002 enters phase Ib trial in HCV
Read More
Corus enters licensing deal with BattellePharma for asthma drug delivery technology
Read More
Lilly and Teijin to jointly develop and commercialize Xigris in Japan
Read More
KW-2871 enters malignant melanoma study
Read More
Tularik and Sankyo collaborate on GPCR drug discovery
Read More
Multiple doses of NV-1020 feasible; efficacy demonstrated in pancreatic cancer peritoneal metastasis
Read More
Potent anticonvulsant activity reported for nonpeptide galanin receptor agonist
Read More
Guggulsterone effectively reduces cholesterol via antagonism of FXR receptor
Read More
Crystal structure of MECDP-synthase described by University of Dundee group
Read More
Targeted Genetics' arthritis program discussed at ASGT meeting, heads for clinical trials
Read More
INGN-241: new data presented at the Boston gene therapy meeting
Read More
Medarex and IDM partner to develop Cell Drugs in combination with MDX-010
Read More
Byk files for approval of ciclesonide for asthma in Canada
Read More
AC-3056 shows promise in atherosclerosis
Read More
Miravant and Bausch & Lomb to review SnET2 data with license option
Read More
Pharmexa updates AutoVac HER-2 DNA pharmaccine trial progress
Read More
Vasogen plans pivotal trial of immune modulation therapy
Read More
Sheffield completes phase I studies of NanoCrystal Budesonide product
Read More
MLN-341 (Velcade) enters pivotal phase III in multiple myeloma
Read More
I2S gives positive results in phase I/II Hunter's syndrome study
Read More
